Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 20/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407881 | 0.81 | TACR1 (1.00) | TACR1 | |
| SCHEMBL6410360 | 0.80 | TACR1 (0.82) | TACR1 | |
| SCHEMBL6407978 | 0.80 | TACR1 (0.64) | TACR1 | |
| SCHEMBL6405931 | 0.79 | TACR1 (0.82) | TACR1 | |
| SCHEMBL6410689 | 0.79 | TACR1 (1.00) | TACR1 | |
| SCHEMBL6408899 | 0.78 | TACR1 (0.98) | TACR1 | |
| SCHEMBL6411916 | 0.78 | TACR1 (0.76) | TACR1 | |
| Hydrochloric Acid SCHEMBL6406251 | 0.78 | TACR1 (1.00) | TACR1 | |
| SCHEMBL6408869 | 0.77 | TACR1 (0.85) | TACR1 | |
| SCHEMBL6406086 | 0.76 | TACR1 (0.75) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190175475-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
| US-8541466-B2 | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins | DUKE UNIVERSITY (US) | 2013-09-24 | — | — | US | disclosed |
| US-20050222232-A1 | prostaglandin F analogs, such as 13,14-dihydro-15-(2-benzathiozolyl) pentanor Prostaglandin F1 alpha, with other hair growth stimulant; topically to the skin; can arrest hair loss, reverse hair loss, and promote hair growth; cosmetics | DUKE UNIVERSITY | 2005-10-06 | — | — | US | disclosed |
| US-20050038072-A1 | Nitrogeneous cyclic ketone derivative, process for producing the same, and use | TAKEDA CHEMICAL INDUSTRIES, LTD. | 2005-02-17 | — | — | US | disclosed |
| EP-1460062-A1 | NITROGENOUS CYCLIC KETONE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190175475-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS | PTGES, PTGS1, PTGS2 | TACR1 1695/4885 |
| US-20050222232-A1 | prostaglandin F analogs, such as 13,14-dihydro-15-(2-benzathiozolyl) pentanor Prostaglandin F1 alpha, with other hair growth stimulant; topically to the skin; can arrest hair loss, reverse hair loss, and promote hair growth; cosmetics | PTGIR, PTGDR, PTGS1 | TACR1 434/4885 |
| US-20050038072-A1 | Nitrogeneous cyclic ketone derivative, process for producing the same, and use | BDKRB1, BDKRB2, TACR1 | TACR1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.